A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus
Clinical trial NCT00203151 · TERMINATED
Trial details
- NCT number
- NCT00203151
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2007-02-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.